Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 293 (RN7SKP293) is a non-functional RNA gene annotation, categorized as a pseudogene related to the genuine 7SK small nuclear RNA (7SK snRNA). Unlike the canonical 7SK snRNA, which is integral to the regulation of transcription elongation through its ribonucleoprotein complex and control of positive transcription elongation factor b (P-TEFb)[1][2][3][4], RN7SKP293 lacks coding potential, structural assembly, or biological activity. There is no evidence for a physiological or clinical function, nor a role in disease, and it is not a therapeutic target[5]. Common database entries refer to sequence homology, but do not ascribe any molecular function to RN7SKP293. If information about a functional target was intended, refer to "7SK small nuclear RNA" (abbreviation: 7SK; canonical name: 7SK small nuclear RNA), which is a well-studied regulator of transcriptional elongation and potential indirect therapeutic interest in oncology and virology[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK Pseudogene 293 (RN7SKP293).